Imunon, INC. (IMNN) SEC Filings — 2024
24 SEC filings for Imunon, INC. (IMNN) in 2024.
Filings
- Imunon, Inc. Faces Delisting Concerns — 8-K · Nov 27, 2024
- Imunon, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Imunon, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Imunon, Inc. Files Q3 2024 10-Q — 10-Q · Nov 7, 2024
- Imunon, Inc. Files 8-K: Officer/Director Changes & Compensation — 8-K · Oct 7, 2024
- Imunon, Inc. Files S-1/A Amendment — S-1/A · Sep 20, 2024
- Imunon, Inc. Files 8-K Report — 8-K · Sep 3, 2024
- Imunon, Inc. Files S-1 for Public Offering — S-1 · Aug 29, 2024
- Imunon, Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 14, 2024
- Imunon, INC. SC 13G Filing — SC 13G · Aug 5, 2024
- Imunon, Inc. Files 8-K: Procedural Update — 8-K · Aug 1, 2024
- Imunon Secures $1.5M in Preferred Stock Financing — 8-K · Jul 31, 2024
- Imunon, Inc. Files 8-K with Regulatory Updates — 8-K · Jul 30, 2024
- Imunon, Inc. Announces Special Stockholder Meeting for Reverse Stock Split — 8-K · Jun 13, 2024
- Imunon, Inc. Announces Director Departure and Election — 8-K · May 20, 2024
- Imunon, Inc. Files 8-K for Operations and Financials — 8-K · May 13, 2024
- Imunon, Inc. Reports Director/Officer Changes & Compensatory Arrangements — 8-K · May 8, 2024
- Imunon, Inc. Announces Virtual Annual Meeting of Stockholders on June 12, 2024 — DEF 14A · Apr 26, 2024
- Imunon, Inc. Terminates Merger with Eterna Therapeutics — 8-K · Apr 11, 2024
- Imunon, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Imunon, Inc. Files 8-K for Amendments and Financials — 8-K · Mar 18, 2024
- Imunon, Inc. Reports Board and Executive Changes — 8-K · Mar 12, 2024
- Imunon, Inc. Files Amendment No. 2 to Form S-1 Registration Statement — S-1/A · Feb 9, 2024
- Imunon, Inc. Files Amendment No. 1 to S-1 Registration Statement — S-1/A · Jan 18, 2024